UCB Pharma Limited

208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: Medicalinformationuk@ucb.com
Customer Care direct line: +44 (0) 1773 510123

Patient Information Leaflet last updated on the eMC: 24/01/2012
PIL Xyzal 0.5 mg/ml oral solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 07/10/2011 and displayed until 24/01/2012
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 08/04/2011 and displayed until 07/10/2011
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 20/05/2009 and displayed until 08/04/2011
Reasons for adding or updating:
  • Change to how the medicine works
Updated on 18/06/2008 and displayed until 20/05/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/07/2007 and displayed until 18/06/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   levocetirizine dihydrochloride